Follow the people · Insider
Christine Ring
Christine Ring files insider transactions with the SEC as a chief legal officer of Nurix Therapeutics (NRIX). We hold 14 disclosed purchases and sales filed since 12 February 2021, 5 of them in the last 90 days.
- Files forNRIX
- Disclosed buys and sells14 in all, 5 in the last 90 days
- Last disclosure2 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 11 February 2021 — 2 September 2026Chief Legal Officer · Nurix Therapeutics (NRIX)279 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 5,787 shares of Nurix TherapeuticsSEC Form 42 September 2026Common Stock · traded 2 September 2026 · filed 2 September 2026
- ▼ sold on the open market 5,387 shares of Nurix TherapeuticsSEC Form 42 September 2026Common Stock · traded 2 September 2026 · filed 2 September 2026
- ▼ sold on the open market 400 shares of Nurix TherapeuticsSEC Form 42 September 2026Common Stock · traded 2 September 2026 · filed 2 September 2026
- exercised options over 5,787 shares of Nurix Therapeutics (a derivative holding)SEC Form 42 September 2026Employee Stock Option (right to buy) · traded 2 September 2026 · filed 2 September 2026
- exercised options over 5,787 shares of Nurix TherapeuticsSEC Form 43 August 2026Common Stock · traded 3 August 2026 · filed 3 August 2026
- ▼ sold on the open market 16,589 shares of Nurix TherapeuticsSEC Form 43 August 2026Common Stock · traded 3 August 2026 · filed 3 August 2026
- exercised options over 5,787 shares of Nurix Therapeutics (a derivative holding)SEC Form 43 August 2026Employee Stock Option (right to buy) · traded 3 August 2026 · filed 3 August 2026
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 July 2026Common Stock · traded 30 July 2026 · filed 30 July 2026
- exercised options over 2,858 shares of Nurix TherapeuticsSEC Form 430 July 2026Common Stock · traded 30 July 2026 · filed 30 July 2026
- exercised options over 3,572 shares of Nurix TherapeuticsSEC Form 430 July 2026Common Stock · traded 30 July 2026 · filed 30 July 2026
- ▼ sold on the open market 3,847 shares of Nurix TherapeuticsSEC Form 430 July 2026Common Stock · traded 30 July 2026 · filed 30 July 2026
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2026Restricted Stock Units · traded 30 July 2026 · filed 30 July 2026
- exercised options over 2,858 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2026Restricted Stock Units · traded 30 July 2026 · filed 30 July 2026
- exercised options over 3,572 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2026Restricted Stock Units · traded 30 July 2026 · filed 30 July 2026
- exercised options over 5,221 shares of Nurix TherapeuticsSEC Form 42 July 2026Common Stock · traded 2 July 2026 · filed 2 July 2026
- exercised options over 5,787 shares of Nurix TherapeuticsSEC Form 42 July 2026Common Stock · traded 2 July 2026 · filed 2 July 2026
- ▼ sold on the open market 11,008 shares of Nurix TherapeuticsSEC Form 42 July 2026Common Stock · traded 2 July 2026 · filed 2 July 2026
- exercised options over 5,221 shares of Nurix Therapeutics (a derivative holding)SEC Form 42 July 2026Employee Stock Option (right to buy) · traded 2 July 2026 · filed 2 July 2026
- exercised options over 5,787 shares of Nurix Therapeutics (a derivative holding)SEC Form 42 July 2026Employee Stock Option (right to buy) · traded 2 July 2026 · filed 2 July 2026
- exercised options over 13,333 shares of Nurix TherapeuticsSEC Form 425 June 2026Common Stock · traded 25 June 2026 · filed 25 June 2026
- exercised options over 15,602 shares of Nurix TherapeuticsSEC Form 425 June 2026Common Stock · traded 25 June 2026 · filed 25 June 2026
- ▼ sold on the open market 28,935 shares of Nurix TherapeuticsSEC Form 425 June 2026Common Stock · traded 25 June 2026 · filed 25 June 2026
- exercised options over 13,333 shares of Nurix Therapeutics (a derivative holding)SEC Form 425 June 2026Employee Stock Option (right to buy) · traded 25 June 2026 · filed 25 June 2026
- exercised options over 15,602 shares of Nurix Therapeutics (a derivative holding)SEC Form 425 June 2026Employee Stock Option (right to buy) · traded 25 June 2026 · filed 25 June 2026
- exercised options over 3,422 shares of Nurix TherapeuticsSEC Form 42 June 2026Common Stock · traded 2 June 2026 · filed 2 June 2026
- ▼ sold on the open market 8,148 shares of Nurix TherapeuticsSEC Form 42 June 2026Common Stock · traded 2 June 2026 · filed 2 June 2026
- exercised options over 3,422 shares of Nurix Therapeutics (a derivative holding)SEC Form 42 June 2026Employee Stock Option (right to buy) · traded 2 June 2026 · filed 2 June 2026
- ▼ sold on the open market 8,148 shares of Nurix TherapeuticsSEC Form 44 May 2026Common Stock · traded 4 May 2026 · filed 4 May 2026
- ▼ sold on the open market 5,394 shares of Nurix TherapeuticsSEC Form 41 May 2026Common Stock · traded 1 May 2026 · filed 1 May 2026
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 April 2026Common Stock · traded 30 April 2026 · filed 30 April 2026
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 April 2026Common Stock · traded 30 April 2026 · filed 30 April 2026
- exercised options over 2,858 shares of Nurix TherapeuticsSEC Form 430 April 2026Common Stock · traded 30 April 2026 · filed 30 April 2026
- ▼ sold on the open market 3,214 shares of Nurix TherapeuticsSEC Form 430 April 2026Common Stock · traded 30 April 2026 · filed 30 April 2026
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2026Restricted Stock Units · traded 30 April 2026 · filed 30 April 2026
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2026Restricted Stock Units · traded 30 April 2026 · filed 30 April 2026
- exercised options over 2,858 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2026Restricted Stock Units · traded 30 April 2026 · filed 30 April 2026
- ▼ sold on the open market 8,148 shares of Nurix TherapeuticsSEC Form 42 April 2026Common Stock · traded 2 April 2026 · filed 2 April 2026
- ▼ sold on the open market 8,148 shares of Nurix TherapeuticsSEC Form 42 March 2026Common Stock · traded 2 March 2026 · filed 2 March 2026
- ▼ sold on the open market 8,148 shares of Nurix TherapeuticsSEC Form 42 March 2026Common Stock · traded 2 March 2026 · filed 2 March 2026
- was granted 93,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 410 February 2026Employee Stock Option (right to buy) · traded 10 February 2026 · filed 10 February 2026
- was granted 42,875 shares of Nurix Therapeutics (a derivative holding)SEC Form 410 February 2026Restricted Stock Units · traded 10 February 2026 · filed 10 February 2026
- was granted 93,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 410 February 2026Employee Stock Option (right to buy) · traded 10 February 2026 · filed 10 February 2026
- was granted 42,875 shares of Nurix Therapeutics (a derivative holding)SEC Form 410 February 2026Restricted Stock Units · traded 10 February 2026 · filed 10 February 2026
- ▼ sold on the open market 14,261 shares of Nurix TherapeuticsSEC Form 49 February 2026Common Stock · traded 9 February 2026 · filed 9 February 2026
- ▼ sold on the open market 14,261 shares of Nurix TherapeuticsSEC Form 49 February 2026Common Stock · traded 9 February 2026 · filed 9 February 2026
- exercised options over 1,925 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,859 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 1,925 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,859 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,859 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- ▼ sold on the open market 4,333 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- ▼ sold on the open market 88 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 1,925 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 1,925 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 2,859 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- ▼ sold on the open market 4,333 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- ▼ sold on the open market 88 shares of Nurix TherapeuticsSEC Form 430 January 2026Common Stock · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2026Restricted Stock Units · traded 30 January 2026 · filed 30 January 2026
- exercised options over 3,760 shares of Nurix TherapeuticsSEC Form 420 January 2026Common Stock · traded 20 January 2026 · filed 20 January 2026
- ▼ sold on the open market 3,760 shares of Nurix TherapeuticsSEC Form 420 January 2026Common Stock · traded 20 January 2026 · filed 20 January 2026
- exercised options over 3,760 shares of Nurix Therapeutics (a derivative holding)SEC Form 420 January 2026Employee Stock Option (right to buy) · traded 20 January 2026 · filed 20 January 2026
- exercised options over 3,760 shares of Nurix Therapeutics (a derivative holding)SEC Form 420 January 2026Employee Stock Option (right to buy) · traded 20 January 2026 · filed 20 January 2026
- exercised options over 3,760 shares of Nurix TherapeuticsSEC Form 420 January 2026Common Stock · traded 20 January 2026 · filed 20 January 2026
- ▼ sold on the open market 3,760 shares of Nurix TherapeuticsSEC Form 420 January 2026Common Stock · traded 20 January 2026 · filed 20 January 2026
- exercised options over 3,760 shares of Nurix Therapeutics (a derivative holding)SEC Form 418 December 2025Employee Stock Option (right to buy) · traded 18 December 2025 · filed 18 December 2025
- exercised options over 3,760 shares of Nurix TherapeuticsSEC Form 418 December 2025Common Stock · traded 18 December 2025 · filed 18 December 2025
- ▼ sold on the open market 3,560 shares of Nurix TherapeuticsSEC Form 418 December 2025Common Stock · traded 18 December 2025 · filed 18 December 2025
- ▼ sold on the open market 200 shares of Nurix TherapeuticsSEC Form 418 December 2025Common Stock · traded 18 December 2025 · filed 18 December 2025
- exercised options over 37,600 shares of Nurix Therapeutics (a derivative holding)SEC Form 424 November 2025Employee Stock Option (right to buy) · traded 24 November 2025 · filed 24 November 2025
- exercised options over 37,600 shares of Nurix TherapeuticsSEC Form 424 November 2025Common Stock · traded 24 November 2025 · filed 24 November 2025
- ▼ sold on the open market 37,600 shares of Nurix TherapeuticsSEC Form 424 November 2025Common Stock · traded 24 November 2025 · filed 24 November 2025
- exercised options over 1,924 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2025Restricted Stock Units · traded 30 October 2025 · filed 30 October 2025
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2025Restricted Stock Units · traded 30 October 2025 · filed 30 October 2025
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2025Restricted Stock Units · traded 30 October 2025 · filed 30 October 2025
- exercised options over 2,858 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 October 2025Restricted Stock Units · traded 30 October 2025 · filed 30 October 2025
- exercised options over 1,924 shares of Nurix TherapeuticsSEC Form 430 October 2025Common Stock · traded 30 October 2025 · filed 30 October 2025
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 October 2025Common Stock · traded 30 October 2025 · filed 30 October 2025
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 October 2025Common Stock · traded 30 October 2025 · filed 30 October 2025
- exercised options over 2,858 shares of Nurix TherapeuticsSEC Form 430 October 2025Common Stock · traded 30 October 2025 · filed 30 October 2025
- ▼ sold on the open market 3,644 shares of Nurix TherapeuticsSEC Form 430 October 2025Common Stock · traded 30 October 2025 · filed 30 October 2025
- exercised options over 1,924 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2025Restricted Stock Units · traded 30 July 2025 · filed 30 July 2025
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2025Restricted Stock Units · traded 30 July 2025 · filed 30 July 2025
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2025Restricted Stock Units · traded 30 July 2025 · filed 30 July 2025
- exercised options over 2,858 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 July 2025Restricted Stock Units · traded 30 July 2025 · filed 30 July 2025
- exercised options over 1,924 shares of Nurix TherapeuticsSEC Form 430 July 2025Common Stock · traded 30 July 2025 · filed 30 July 2025
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 July 2025Common Stock · traded 30 July 2025 · filed 30 July 2025
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 July 2025Common Stock · traded 30 July 2025 · filed 30 July 2025
- exercised options over 2,858 shares of Nurix TherapeuticsSEC Form 430 July 2025Common Stock · traded 30 July 2025 · filed 30 July 2025
- ▼ sold on the open market 3,841 shares of Nurix TherapeuticsSEC Form 430 July 2025Common Stock · traded 30 July 2025 · filed 30 July 2025
- exercised options over 1,924 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2025Restricted Stock Units · traded 30 April 2025 · filed 30 April 2025
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2025Restricted Stock Units · traded 30 April 2025 · filed 30 April 2025
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 April 2025Restricted Stock Units · traded 30 April 2025 · filed 30 April 2025
- exercised options over 1,924 shares of Nurix TherapeuticsSEC Form 430 April 2025Common Stock · traded 30 April 2025 · filed 30 April 2025
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 April 2025Common Stock · traded 30 April 2025 · filed 30 April 2025
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 April 2025Common Stock · traded 30 April 2025 · filed 30 April 2025
- ▼ sold on the open market 2,894 shares of Nurix TherapeuticsSEC Form 430 April 2025Common Stock · traded 30 April 2025 · filed 30 April 2025
- was granted 75,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 413 February 2025Employee Stock Option (right to buy) · traded 11 February 2025 · filed 13 February 2025
- was granted 34,300 shares of Nurix Therapeutics (a derivative holding)SEC Form 413 February 2025Restricted Stock Units · traded 11 February 2025 · filed 13 February 2025
- exercised options over 223 shares of Nurix Therapeutics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- exercised options over 5,537 shares of Nurix Therapeutics (a derivative holding)SEC Form 43 February 2025Employee Stock Option (right to buy) · traded 31 January 2025 · filed 3 February 2025
- exercised options over 223 shares of Nurix TherapeuticsSEC Form 43 February 2025Common Stock · traded 31 January 2025 · filed 3 February 2025
- exercised options over 5,537 shares of Nurix TherapeuticsSEC Form 43 February 2025Common Stock · traded 31 January 2025 · filed 3 February 2025
- ▼ sold on the open market 5,660 shares of Nurix TherapeuticsSEC Form 43 February 2025Common Stock · traded 31 January 2025 · filed 3 February 2025
- ▼ sold on the open market 100 shares of Nurix TherapeuticsSEC Form 43 February 2025Common Stock · traded 31 January 2025 · filed 3 February 2025
- exercised options over 1,924 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2025Restricted Stock Units · traded 30 January 2025 · filed 30 January 2025
- exercised options over 2,000 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2025Restricted Stock Units · traded 30 January 2025 · filed 30 January 2025
- exercised options over 3,750 shares of Nurix Therapeutics (a derivative holding)SEC Form 430 January 2025Restricted Stock Units · traded 30 January 2025 · filed 30 January 2025
- exercised options over 1,924 shares of Nurix TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- exercised options over 2,000 shares of Nurix TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- exercised options over 3,750 shares of Nurix TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- ▼ sold on the open market 2,929 shares of Nurix TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- ▼ sold on the open market 291 shares of Nurix TherapeuticsSEC Form 430 January 2025Common Stock · traded 30 January 2025 · filed 30 January 2025
- exercised options over 5,760 shares of Nurix Therapeutics (a derivative holding)SEC Form 42 January 2025Employee Stock Option (right to buy) · traded 2 January 2025 · filed 2 January 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.